期刊文献+

急性冠状动脉综合征患者外周血中脂联素水平与基质金属蛋白酶-9及其组织抑制因子-1关系的探讨 被引量:3

Relationship Between MMP-9/TIMP-1 and Adiponectin in Peripheral Blood in Patient With Acute Coronary Syndrome
下载PDF
导出
摘要 目的:探讨急性冠状动脉综合征患者(ACS)外周血中脂联素与基质金属蛋白酶-9(MMP-9)及基质金属蛋白酶组织抑制因子-1(TIMP-1)水平及其相关性的研究。方法:急性心肌梗死组19例,不稳定性心绞痛组31例,稳定性心绞痛组13例,正常对照组22例,检测各组外周血中脂联素、MMP-9、TIMP-1的浓度。各组间采用独立样本的t检验,各参数之间进行单因素的相关分析。结果:急性心肌梗死组、不稳定性心绞痛组分别与正常对照组比较:外周血清中脂联素的浓度、TIMP-1的浓度均显著降低(P<0.05~0.01),MMP-9/TIMP-1及MMP-9的浓度则均显著升高(P<0.05~0.01);急性心肌梗死组、不稳定性心绞痛组与稳定性心绞痛组比较,脂联素的浓度显著降低(P<0.05~0.01),MMP-9/TIMP-1升高(P<0.05~0.01);稳定性心绞痛组与正常对照组比较各指标间无明显差异。相关性分析中:脂联素与MMP-9之间无相关性(r=-0.248,P>0.05),脂联素与TIMP-1有显著相关性(r=0.408,P<0.01),脂联素与MMP-9/TIMP-1之间有显著相关性(r=-0.478,P<0.001)。结论:ACS患者中,脂联素的分泌减少,导致TIMP-1的分泌也减少,MMP-9/TIMP-1平衡破坏,可能是急性冠状动脉综合征发生的重要因素。 Objective : To study the changes of matrix metalloproteinase-9 ( MMP-9 )/tissue inhibitors of metalloprnteinase-1 ( TIMP-1 ) and adiponectin in peripheral blood in patients with acute coronau' syndrome (ACS) and explore the relationship between them. Methods: Patients with AMI( n = 19), unstable angina (n = 31 ) ,stable angina( n = 13 ) and healthy control group (n = 22) were included in this study. All the results were obtained by ABC-ELISA and analysed by independent t-test and correlation analysis. Results: In groups of AMI and UA, the levels of TIMP-1 and adiponectin in peripheral blood were significantly decreased compared with the healthy control group (P 〈 0.05-0. 01 ) , but MMP-9 level and MMP-9/TIMP-1 value were significantly increased (P 〈 0. 05-0. 01 ). Adiponectin was obviously decreased (P 〈 0. 05-0. 01 ) and MMP-9/TIMP-1 was relatively increased (P〈0. 01 ,p 〉0. 05)in AMI and UA groups compared with the SA group. Between the SA group and the healthy control group there were no obvious difference. The concentration of adiponectin was significantly positively correlated with TIMP-1 (r = 0. 408, P 〈0.01 ) and significantly negatively correlated with MMP-9/TIMP-1 ( r =0. 478, P 〈0. 001 ). Conelusion: The decreased adiponectin affects the stabilization of plaque in coronary artery, and its relation with MMP-9/ TIMP-1 may be an important factor in the oceurence of ACS.
出处 《中国循环杂志》 CSCD 北大核心 2007年第3期180-182,共3页 Chinese Circulation Journal
关键词 脂联素 急性冠状动脉综合征 基质金属蛋白酶-9 基质金属蛋白酶组织抑制闪子-1 Adiponectin Acute coronary syndrome Matrix metalloproteinase-9 Tissue inhibitors of metalloproteinase-1
  • 相关文献

参考文献10

  • 1Arita Y,Kihara S,Ouchi N,et al.Paradoxical decrease of an adipose specific protein,adiponectin,in obesity.Biochem Biophys Res Commun,1999,257:79283.
  • 2Lyon C J,Law RE,Hsueh WA.Minireview:adiposity,inflammation,and atherogenesis.Endocrinology,2003,144:2195-2200.
  • 3Ouchi N,Kihara S,Arita Y,et al.Novel modulator for endothelial adhesion molecules:adipocytederived plasma protein adiponectin.Circulation,1999,100:2473-2476.
  • 4Hotta K,Funahashi T,Arita Y,et al.Plasma concentrations of a novel,adipose-specific protein,adiponectin,in type 2 diabetic patients.Arterioscler Thromb Vasc Biol,2000,20:1595-1599.
  • 5Noji Y,Kajinami K,Kawashirim M,et al.Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis.Clin Chem Lab Med,2001,39:3802-3808.
  • 6De Smet BJ,de kleijn D,Hanemaaijer R,et al.Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty:a study in the atherosclerotic Yucatan micropig.Circulation,2000,101:2962-2967.
  • 7Ross R.Atherosclerosis-aninflammatorydisease.N Engl J Med,1999,340:115-126.
  • 8Dollery CM,McEwan JR,Henney AM.Matrix metalloproteinases and cardiovascular disease.Circ Res,1995,77:863-868.
  • 9Ouchi N,Kihara S,Arita Y,et al.Adiponectin,an Adipocyte-Derived Plasma Protein,Inhibits Endothelial NF-κB Signaling Through a cAMPDependent Pathway.Circulation,2000,102:1296.
  • 10Masahiro K,Shinji K,Noriyuki O,et al.adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10Expression in Human Macrophages.Circulation,2004,109:2046-2049.

同被引文献23

  • 1季永侠,袁荣峰.VD大鼠血清及脑脊液中IL-6水平变化[J].中国实用医药,2007,2(9):28-29. 被引量:6
  • 2曹慧丽,申晓彧,王国风,祝河忠.急性冠脉综合征患者抵抗素和P-选择素的相关性研究[J].中国心血管病研究,2009,7(10):750-753. 被引量:1
  • 3贾建军,王鲁宁,汤洪川.血管性痴呆的发病机制[J].中华老年心脑血管病杂志,2000,2(2):139-142. 被引量:19
  • 4王远程,叶志斌,周钦,张宗梁,吴兆龙.丙丁酚抑制氧化型低密度脂蛋白诱导系膜细胞转化生长因子-β_1表达[J].复旦学报(医学版),2005,32(2):151-154. 被引量:9
  • 5中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 6Fukutomi T,Takeda Y,Suzuki S,et al.High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin,a new HMG-CoA reductase inhibitor[J].lnt JCardiol,2010,141 (3):320-322.
  • 7Sasaki J,Ikeda Y,Kuribayashi T,et al.A 52-week,randomized,openlabel,parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance[J].Clin Ther,2008,30(6):1089-1101.
  • 8Yoshika M,Komiyama Y,Masuda M,et al.Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin Ⅱ,type-1 receptor antagonists[J].Exp Hypertens,2010,32(6):341-346.
  • 9Takemoto M,Liao - Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors[J].Artedoscler Thromb Vasc Biol,2001,21(11):1712-1719.
  • 10Hiraoka M,Nitta N,Nagai M,et al.MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-,but not ERK1/2-dependent pathway[J].Life Sci,2004,75(11):1333-1341.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部